Annals of Oncology

In this issue:

In this issue
Ann Oncol 3: 579.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 3: 579.
[PDF] [Request Permissions]

News:

News: AIDS and cancer: Let's begin thinking globally
Ann Oncol 3: 580.
[PDF] [Request Permissions]

MRS as an early indicator of tumour response
Ann Oncol 3: 580-581.
[PDF] [Request Permissions]

ESO: A decade of cancer education and training in Europe
Ann Oncol 3: 581-582.
[PDF] [Request Permissions]

The American Congress questions meta-analysis
Ann Oncol 3: 582.
[PDF] [Request Permissions]

Radon levels too high in Swiss and British studies
Ann Oncol 3: 582.
[PDF] [Request Permissions]

Rio: Just an occasion to go swimming?
Ann Oncol 3: 582.
[PDF] [Request Permissions]

To fight AIDS, the Swiss Government ready to provide heroin
Ann Oncol 3: 583.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 3: 583-584.
[PDF] [Request Permissions]

First ESMO course: A good beginning
Ann Oncol 3: 584.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 3: 584-585.
[PDF] [Request Permissions]

Editorials:

V.C. Jordon

A therapeutic withdrawal can make a strategic advance
Ann Oncol 3: 587-588.
[PDF] [Request Permissions]

V. C. Jordan

Editorial: A therapeutic withdrawal can make a strategic advance
Ann Oncol 3: 595.
[PDF] [Request Permissions]

Jean-Philippe Bonjour and René Rizzoli

Editorial: Antiosteolytic agents in the management of hypercalcemia
Ann Oncol 3: 595.
[PDF] [Request Permissions]

P. Workman

Editorial: Infusional anthracyclines: Is slower better? If so, why?
Ann Oncol 3: 595.
[PDF] [Request Permissions]

Special articles:

D. Serraino, S. Franceschi, U. Tirelli, and S. Monfardini

Special article: The epidemiology of acquired immunodeficiency syndrome and associated tumours in Europe
Ann Oncol 3: 595-603.
[Abstract] [PDF] [Request Permissions]

Classified advertisements from ESMO-members and meeting announcements:

Classified advertisements from ESMO-members and meeting announcements
Ann Oncol 3: 604.
[PDF] [Request Permissions]

Review:

M. E. R. O'Brien and B. E. Souberbielle

Review: Allergic reactions to cytotoxic drugs - an update
Ann Oncol 3: 605-610.
[PDF] [Request Permissions]

Original articles:

A. Howell, D. J. Dodwell, H. Anderson, and J. Redford

Original article: Response after withdrawal of tamoxifen and progestogens in advanced breast cancer
Ann Oncol 3: 611-617.
[Abstract] [PDF] [Request Permissions]

B. Thürlimann, R. Waldburger, H. J. Senn, and D. Thiébaud

Original article: Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: A prospective randomized crossover trial
Ann Oncol 3: 619-623.
[Abstract] [PDF] [Request Permissions]

C. La Vecchia, E. Negri, P. Bruzzi, G. Dardanoni, A. Decarli, S. Franceschi, D. Palli, and R. Talamini

Original article: The role of age at menarche and at menopause on breast cancer risk: Combined evidence from four case-control studies
Ann Oncol 3: 625-629.
[Abstract] [PDF] [Request Permissions]

N. Pavlidis, P. Kosmidis, D. Skarlos, E. Briassoutis, M. Beer, D. Theoharis, D. Bafaloukos, A. Maraveyas, and G. Fountzilas

Original article: Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site: A Hellenic Cooperative Oncology Group Study
Ann Oncol 3: 631-634.
[Abstract] [PDF] [Request Permissions]

F. Tiensuu Janson, L. Rönnblom, H. Ahlström, D. Grandér, G. Alm, S. Einhorn, and K. Öberg

Original article: Treatment with alpha-interferon versus alpha-interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: A randomized trial
Ann Oncol 3: 635-638.
[Abstract] [PDF] [Request Permissions]

C. Dumontet, Y. Bastion, P. Felman, M. Ffrench, M. Blanc, P. Y. Peaud, and B. Coiffier

Original article: Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen
Ann Oncol 3: 639-644.
[Abstract] [PDF] [Request Permissions]

G. Pichert, J. Peters, R. A. Stahel, C. Dommann, R. Joss, J. O. Gebbers, T. Kroner, H. Sulser, H. P. Honegger, R. Maurer, and S. Pampallona

Original article: Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: Clinical results and analysis of prognostic factors
Ann Oncol 3: 645-649.
[Abstract] [PDF] [Request Permissions]

J. Robert and N. B. Bui

Original article: Pharmacokinetics and metabolism of epirubicin administered as i.v. bolus and 48-h infusion in patients with advanced soft-tissue sarcoma
Ann Oncol 3: 651-656.
[Abstract] [PDF] [Request Permissions]

Book reviews:

C. Sessa

Book review
Ann Oncol 3: 629.
[PDF] [Request Permissions]

J. Bernier

Book review
Ann Oncol 3: 638.
[PDF] [Request Permissions]

H. H. Hansen

Book review
Ann Oncol 3: 644.
[PDF] [Request Permissions]

Short reports:

C. Louvet, A. de Gramont, B. Demuynck, C. Varette, K. Beerblock, M. Bennamoun, and M. Krulik

Short report: Bi-weekly 2-day schedule of high-dose folinic acid, 5-fluorouracil bolus and infusion in pretreated advanced epithelial ovarian cancer: A phase II study
Ann Oncol 3: 657-658.
[Abstract] [PDF] [Request Permissions]

R. Natale, R. Wheeler, M. Moore, B. Dallaire, W. Lynch, R. Carlson, A. Grillo-Lopez, and L. Gyves

Short report: Multicenter phase II trial of brequinar sodium in patients with advanced melanoma
Ann Oncol 3: 659-660.
[Abstract] [PDF] [Request Permissions]

M. Pecherstorfer and D. Thiébaud

Short report: Treatment of resistant tumor-induced hypercalcemia with escalating doses of pamidronate (APD)
Ann Oncol 3: 661-663.
[PDF] [Request Permissions]

Advertisements in this issue:

The University of Berne, Switzerland (Faculty of Medicine/Inselspital)
Ann Oncol 3: 663.
[PDF] [Request Permissions]

Supportive Care in Cancer
Ann Oncol 3: 668.
[PDF] [Request Permissions]

Letters:

B. J. Marroni, E. B. Ludwig, M. J. Almeida, A. L. Brunetto, and G. Schwartsmann

Interferon alpha-2-beta enhances immunoscintigraphic localization of monoclonal antibody in malignant melanoma
Ann Oncol 3: 664.
[PDF] [Request Permissions]

J. Seymour

Mechanisms of hypercalcemia in lymphomas
Ann Oncol 3: 664-665.
[PDF] [Request Permissions]

D. J. Dodwell

The above letter was referred to the author, who responds as follows:
Ann Oncol 3: 665.
[PDF] [Request Permissions]

J.B. Lippincott Company:

J.B. Lippincott Company
Ann Oncol 3: 667.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.